Clinical management and humoral immune responses to rabies post-exposure prophylaxis among three patients who received solid organs from a donor with rabies

Transplant Infectious Disease

Volumn 17, Issue 3, 2015, Pages 389-395

  Vora, N M ^a   Orciari, L A ^a   Niezgoda, M ^a   Selvaggi, G ^b   Stosor, V ^c   Lyon, G M ^d   Wallace, R M ^a   Gabel, J ^e   Stanek, D R ^f   Jenkins, P ^f   Shiferaw, M ^a   Yager, P ^a   Jackson, F ^a   Hanlon, C A ^a   Damon, I ^a   Blanton, J D ^a   Recuenco, S ^a   Franka, R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GEORGIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^f FLORIDA DEPARTMENT OF HEALTH   (United States)

Author keywords

Post exposure prophylaxis; Rabies; Solid organ transplantation

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; BASILIXIMAB; CD3 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; NEUTRALIZING ANTIBODY; ORAL ANTIDIABETIC AGENT; PREDNISONE; RABIES IMMUNOGLOBULIN; RABIES VACCINE; TACROLIMUS; VIRUS ANTIBODY; VIRUS RNA;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY RESPONSE; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY FAILURE; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; END STAGE LIVER DISEASE; FLOW CYTOMETRY; GRAFT RECIPIENT; HEART GRAFT; HEART MUSCLE BIOPSY; HERPES ZOSTER; HUMAN; HUMORAL IMMUNITY; HYPERTENSION; HYPERTENSIVE NEPHROPATHY; IMMUNE FUNCTION TEST; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY GRAFT; LIVER GRAFT; MAINTENANCE THERAPY; MALE; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; ORGAN DONOR; ORGAN TRANSPLANTATION; POST EXPOSURE PROPHYLAXIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RABIES; RABIES VIRUS; RAPID FLUORESCENT FOCUS INHIBITION TEST; SEROLOGY; SINGLE DRUG DOSE; VIRUS DETECTION; ADVERSE EFFECTS; BLOOD; DONOR; HEART TRANSPLANTATION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; RETROSPECTIVE STUDY; TRANSMISSION; TREATMENT OUTCOME;

ADULT; ANTIBODIES, VIRAL; HEART TRANSPLANTATION; HUMANS; IMMUNITY, HUMORAL; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POST-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES; RABIES VIRUS; RETROSPECTIVE STUDIES; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84930764152     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12393     Document Type: Article

References (28)

1. Knobel DL, Cleaveland S, Coleman PG, et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005; 83 (5): 360-368.
2. Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008; 57 (RR-3): 1-28.
3. Rupprecht CE, Briggs D, Brown CM, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010; 59 (RR-2): 1-9.
4. Rodriguez-Romo R, Morales-Buenrostro LE, Lecuona L, et al. Immune response after rabies vaccine in a kidney transplant recipient. Transpl Infect Dis 2011; 13 (5): 492-495.
5. Kopel E, Oren G, Sidi Y, David D. Inadequate antibody response to rabies vaccine in immunocompromised patient. Emerg Infect Dis 2012; 18 (9): 1493-1495.
6. Eckerle I, Rosenberger KD, Zwahlen M, Junghanss T. Serologic vaccination response after solid organ transplantation: a systematic review. PLoS One 2013; 8 (2): e56974.
7. Cramer CH, Shieck V, Thomas SE, Kershaw DB, Magee JC, Lopez MJ. Immune response to rabies vaccination in pediatric transplant patients. Pediatr Transplant 2008; 12 (8): 874-877.
8. Vetter JM, Frisch L, Drosten C, et al. Survival after transplantation of corneas from a rabies-infected donor. Cornea 2011; 30 (2): 241-244.
9. Maier T, Schwarting A, Mauer D, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis 2010; 50 (8): 1112-1119.
10. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352 (11): 1103-1111.
11. Vora NM, Basavaraju SV, Feldman KA, et al. Raccoon rabies virus variant transmission through solid organ transplantation. JAMA 2013; 310 (4): 398-407.
12. Wallace RM, Stanek D, Griese S, et al. A large-scale, rapid public health response to rabies in an organ recipient and the previously undiagnosed organ donor. Zoonoses Public Health 2014; 61 (8): 560-570.
13. Rabies Serology. Available at: http://www.cdc.gov/rabies/specific_groups/doctors/serology.html (accessed on January 24, 2015).
14. Noah DL, Drenzek CL, Smith JS, et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 1998; 128 (11): 922-930.
15. Warner CK, Zaki SR, Shieh WJ, et al. Laboratory investigation of human deaths from vampire bat rabies in Peru. Am J Trop Med Hyg 1999; 60 (3): 502-507.
16. Sun Q, Gao X, Wang H, Ko DS, Li XC. A new era for organ transplantation in China. Lancet 2014; 383 (9933): 1971-1972.
17. Sitthi-Amorn C, Jiratanavattana V, Keoyoo J, Sonpunya N. The diagnostic properties of laboratory tests for rabies. Int J Epidemiol 1987; 16 (4): 602-605.
18. Gilbert AT, Petersen BW, Recuenco S, et al. Evidence of rabies virus exposure among humans in the Peruvian Amazon. Am J Trop Med Hyg 2012; 87 (2): 206-215.
19. Gibbons RV, Rupprecht CE. Postexposure rabies prophylaxis in immunosuppressed patients. JAMA 2001; 285 (12): 1574-1575.
20. Dean DJ, Baer GM, Thompson WR. Studies on the local treatment of rabies-infected wounds. Bull World Health Organ 1963; 28 (4): 477-486.
21. Kaplan MM, Cohen D, Koprowski H, Dean D, Ferrigan L. Studies on the local treatment of wounds for the prevention of rabies. Bull World Health Organ 1962; 26: 765-775.
22. WHO Expert Consultation on Rabies. 2013. Available at: http://apps.who.int/iris/bitstream/10665/85346/1/9789240690943_eng.pdf (accessed on January 24, 2015).
23. Christian KA, Blanton JD, Auslander M, Rupprecht CE. Epidemiology of rabies post-exposure prophylaxis-United States of America, 2006-2008. Vaccine 2009; 27 (51): 7156-7161.
24. Hay E, Derazon H, Bukish N, Scharf S, Rishpon S. Postexposure rabies prophylaxis in a patient with lymphoma. JAMA 2001; 285 (2): 166-167.
25. Thisyakorn U, Pancharoen C, Ruxrungtham K, et al. Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1. Clin Infect Dis 2000; 30 (1): 218.
26. Jaijaroensup W, Tantawichien T, Khawplod P, Tepsumethanon S, Wilde H. Postexposure rabies vaccination in patients infected with human immunodeficiency virus. Clin Infect Dis 1999; 28 (4): 913-914.
27. Gelinck LB, Jol-van der Zijde CM, Jansen-Hoogendijk AM, et al. Restoration of the antibody response upon rabies vaccination in HIV-infected patients treated with HAART. AIDS 2009; 23 (18): 2451-2458.
28. Moon HH, Kim TS, Roh YN, et al. Can immune function assay predict infection or recovery? Transplant Proc 2012; 44 (4): 1048-1051.